Current response-predictive biomarkers for ICI mainly include features of the tumour cells, such as PD-L1 expression, mismatch repair deficiency and tumour mutation burden (TMB).22, 23, 24 However, the predictive accuracy of these biomarkers is only modest.25 The gene discussed is CD274; the disease is neoplasm.